Discussion about this post

User's avatar
jefke's avatar

Hey, thanks for the write-up. I was actually just digging into this one myself over the weekend. Couple of remarks:

- "expect free cash flow to rise and average around €600m a year from 2026 through 2030"

wouldn't this be a bit higher if they can deploy all their growth capex with minimum of 13% "OCR" when fully operational (after 2-3y?). So growth spend doesn't immeadiately turn into extra earnings, but with a couple years lag. I think the bull case has to be that if you think management can invest at these returns, earnings/FCF will rise nicely the coming years

- you say net debt to free cash flow of around 5.5x and thus high. But if you check the more commonly use net debt to ebitda, Vopak seems underlevered (imo)especially with more and more business linked to longer term contracts.

Capital Employed's avatar

Very interesting write-up, will add it to our Best Stock Pitches letter.

12 more comments...

No posts

Ready for more?